San Diego's Palkion Chases Amgen (AMGN)'s Big Market, Joins Race to Develop Oral Anemia Drug
9/1/2009 8:18:53 AM
Xconomy.com -- Amgen’s big break came in the 1980s when it learned how to stimulate the body to make more oxygen-carrying red blood cells. Nobody has topped this achievement for the treatment of anemia in the past 20 years. But now San Diego’s Palkion has joined a list of competitors that hope to capture some billions of their own with a more convenient oral pill that aims to do the same thing as Amgen’s injection.
comments powered by